Skip to content
    Drishti.money
    Earnings calls

    Mankind Pharma concall ledger

    Every earnings call for MANKIND — management tone, guidance, KPIs and promise tracking, quarter by quarter.

    MANKIND · 5 transcripts · Healthcare · latest Q4 FY26
    Q1 FY26Published 01 Aug 2025Call held 01 Aug 2025

    MANKIND Q1 FY26 Earnings Call Transcript & Analysis

    Revenue₹3,570 cr+25% YoYEBITDA₹850 cr+26% YoYEBITDA Margin23.8%−1% YoYPAT₹445 cr−17% YoYGross Margin70.5%−1% YoY

    Revenue ₹3,570 cr (+24% YoY); EBITDA ₹850 cr (+26% YoY); EBITDA Margin (Adjusted) 23.8% (−1% YoY). Overall revenues increased to ₹3,570 crores, up 24.5% YoY.

    Read full transcript & analysis